retatrutide phase 2 A clinical trial demonstrates that #retatrutide, a triple agonist of the GIP, GLP-1, and glucagon receptors, results in up to 82% reduction in liver fat #MASLD @ArunJSanyalVCU A Study of Retatrutide (LY3437943)
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12























